Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder.
暂无分享,去创建一个
M. Landén | S. Erhardt | M. Samuelsson | G. Engberg | J. Söderlund | L. Walther-Jallow | C. Johansson | S. Olsson
[1] E. Jönsson,et al. Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder. , 2010, Journal of psychiatry & neuroscience : JPN.
[2] S. Rapoport,et al. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients , 2010, Molecular Psychiatry.
[3] J. Schröder,et al. Activation of brain interleukin-1β in schizophrenia , 2009, Molecular Psychiatry.
[4] M. Thase,et al. A history of childhood attention‐deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD , 2009, Acta psychiatrica Scandinavica.
[5] P. Visscher,et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.
[6] E. Brietzke,et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. , 2009, Journal of affective disorders.
[7] Martin Samuelsson,et al. Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity , 2009, Biological Psychiatry.
[8] R. McIntyre,et al. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. , 2009, The Journal of clinical psychiatry.
[9] R. Lam,et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. , 2009, The international journal of neuropsychopharmacology.
[10] Tyrone D. Cannon,et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study , 2009, The Lancet.
[11] M. Bourin,et al. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder , 2007, Acta psychiatrica Scandinavica. Supplementum.
[12] M. E. Hernández,et al. Immune variations in bipolar disorder: phasic differences. , 2007, Bipolar disorders.
[13] K. Shirey,et al. Upregulation of IFN-gamma receptor expression by proinflammatory cytokines influences IDO activation in epithelial cells. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[14] B. Maier,et al. Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study. , 2005, Journal of neurotrauma.
[15] B. Gutiérrez,et al. Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder , 2004, Journal of Medical Genetics.
[16] D. Kupfer,et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD) , 2003, Biological Psychiatry.
[17] R. Schwarcz,et al. The Brain Metabolite Kynurenic Acid Inhibits α7 Nicotinic Receptor Activity and Increases Non-α7 Nicotinic Receptor Expression: Physiopathological Implications , 2001, The Journal of Neuroscience.
[18] F. Chiarelli,et al. Effect of anticonvulsant drugs on interleukins-1, -2 and -6 and monocyte chemoattractant protein-1 , 2001, Clinical and Experimental Medicine.
[19] T. Babcock,et al. Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells. , 2000, Cytokine.
[20] J. Levine,et al. Cerebrospinal Cytokine Levels in Patients with Acute Depression , 1999, Neuropsychobiology.
[21] C. Parsons,et al. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization. , 1997, The Journal of pharmacology and experimental therapeutics.
[22] C. Grossman,et al. Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor. , 1988, European journal of pharmacology.
[23] R. Dantzer,et al. From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.
[24] M. Pickering,et al. Pro-inflammatory cytokines and their effects in the dentate gyrus. , 2007, Progress in brain research.
[25] F. Gardoni,et al. Cytokines and neuronal ion channels in health and disease. , 2007, International review of neurobiology.
[26] R. Schwarcz,et al. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[27] M. First,et al. Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .
[28] M. First,et al. Structured Clinical Interview for DSM-IV Axis I Disorders , 1997 .